Leadership

< BACK TO ALL LEADERSHIP

adam feinstein

Adam Feinstein is the Managing Partner and Founder of Vesey Street Capital Partners (VSCP), a private equity firm serving the healthcare sector with a focus on middle-market buyouts. He has twenty-five years of experience working with several leading healthcare services companies. Prior to founding VSCP, Feinstein acted as Senior Vice President of Corporate Development, Strategic Planning and Office of the CEO at Laboratory Corporation of America Holdings (LabCorp), where he oversaw mergers and acquisitions, corporate development, strategic partnerships and corporate strategy. He also managed the company’s partnerships with large hospital systems and created the LabCorp private equity investment vehicle. Before joining LabCorp, Feinstein covered and conducted the health care facilities and services research teams for Lehman Brothers Holdings (Barclays Capital) as Managing Director of Equity Research. He was ranked number one in the Institutional Investor All-America Research Survey in the healthcare sector and was considered the top healthcare services analyst on Wall Street for many years.

Feinstein serves as Chairman of the Board at HealthChannels (ScribeAmerica) and Elite Body Sculpture and as a member of the Board of Directors at PathGroup. He is a former board member of Surgery Partners (NASDAQ: SGRY) and Imedex. He is a CFA charterholder and a graduate of the Smith School at the University of Maryland at College Park and the Nashville Healthcare Council Fellows program.

< BACK TO ALL LEADERSHIP

martha bayliss

Martha Bayliss is a founding member of QualityMetric. She has served as a member of the measurement science team for many years and has acted as General Manager from 2016 through its acquisition by Vesey Street Capital Partners. Bayliss possesses more than twenty-five years of experience in patient-reported outcomes (PROs), providing business leadership and strategic consultation on PRO clinical trial integration, marketing and communications initiatives, program evaluation studies and other studies across the healthcare spectrum.

After several years focused on the measurement of health outcomes, Bayliss has begun pursuing clinical social work through a master’s degree in social counseling at Simmons University to help young people change the trajectory of their health and well-being. She is a graduate of Amherst College and holds a master’s degree from the Harvard University School of Public Health.

< BACK TO ALL LEADERSHIP

dr. amy grogg

Dr. Amy Grogg is an experienced healthcare executive with more than twenty-five years of experience in the pharmaceutical and healthcare services and distribution industries who has most recently acted as Senior Vice President of Strategy and Commercialization for AmerisourceBergen. There, Dr. Grogg developed strategies to advance the company’s leadership in pharmaceutical services and position AmerisourceBergen as the preferred commercialization partner for pharmaceutical manufacturers. She also held operational responsibility for Xcenda, CenterX and Cubixx Solutions. Her previous role at AmerisourceBergen was President of Consulting Services, in which she led the growth of a portfolio of companies that included Xcenda, Innomar Strategies and Lash Group. Prior to joining AmerisourceBergen, Dr. Grogg spent more than a decade in the pharmaceutical industry, primarily at Johnson & Johnson, leading teams responsible for health economic, quality of life and patient-reported outcomes research studies for all of the company’s marketed products in the United States.

Dr. Grogg received her Doctor of Pharmacy from Mercer University and completed a two-year fellowship in pharmacoeconomics at Sandoz Pharmaceuticals Corporation and the University of South Carolina.

< BACK TO ALL LEADERSHIP

marc kramer

Marc Kramer is a founding partner at the New York City based law firm Rolnick Kramer Sadighi LLP, representing professional investors such as hedge funds, mutual funds and private equity funds in securities fraud. Over a career spanning more than thirty years, Kramer focused on value-generating litigation that has recovered over $1 billion for investors through class action opt-out and direct actions, bondholders' rights and investor appraisal rights. Representative clients include Appaloosa Management, Franklin Templeton Investments, SunAmerica Asset Management, Balyasny Asset Management, Highfields Capital Management, Vesey Street Capital Partners, Pennant Capital Management, Nokota Management, Chatham Asset Management, Discovery Capital Management, Owl Creek Asset Management, Fred Alger Management, Jet Capital and Special Situations Funds.

In addition to serving as a board member for the David Tepper Charitable Foundation and the Golda Och Academy Foundation, Kramer serves as a member of the Board of Governors for Hillel International and a member of the Board of Directors for the Center for Israel Education. He is a graduate of Pennsylvania State University, the Dickinson School of Law, Rutgers and the State University of New Jersey.

< BACK TO ALL LEADERSHIP

larry marsh

Larry Marsh possesses a background of close to thirty years in the healthcare industry as a senior healthcare executive and Wall Street veteran. Marsh created the Lehman Brothers Holdings (Barclays Capital) healthcare services team and served as Executive Vice President of New Market Development and Chief Strategy Officer at AmerisourceBergen, where he helped the company complete over thirty merger and acquisition transactions representing more than $7 billion in capital. Prior to AmerisourceBergen, Marsh was the Managing Director of Equity Research at Lehman Brothers Holdings, where he covered and coordinated the healthcare distribution and technology segment.

Marsh is a member of the Board of Directors at HealthChannels and a former member of the Board of Directors at Imedex. He was ranked number one in the Institutional Investor All-America Research Survey and was considered a leading voice on Wall Street for nearly a decade. Marsh received a master’s degree in public health from Columbia University and a master’s and bachelor’s degree from the University of Richmond.

< BACK TO ALL LEADERSHIP

teresa sparks

Teresa Sparks is a seasoned healthcare and finance executive who has most recently served as CFO and Executive Vice President of Envision Healthcare. Previously, she acted as interim CFO of Brookdale Senior Living and CFO and Executive Vice President of Surgery Partners and its predecessor company, Symbion. Sparks began her career in healthcare with Deloitte and went on to obtain extensive public corporate leadership and private equity experience, leading two initial public offerings, a leveraged buy-out and multiple mergers and acquisitions. Her public company knowledge includes strategy development, risk assessment, investor relations and corporate governance.

Sparks serves as the Audit Committee Chair of QualityMetric’s Board of Directors. She is also the Audit Committee Chair and a member of the Compensation, Nomination and Corporate Governance Committees for Harrow Health, Inc. (NASDAQ: HROW). She has acted as Chairperson of the Leadership Health Care program for the Nashville Health Care Council and as a member of the Board of Trustees for Trevecca Nazarene University. Sparks is a graduate of Trevecca Nazarene University with summa cum laude honors and holds an inactive CPA in the state of Tennessee.